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Abstract
Introduction Epidemiological studies rely on data supplied by
central cancer registration sources to be timely, accurate and
complete. Validation studies of such data at a national level are
limited. Data collected for the Million Women Study was used to
compare the level of agreement between the Office for National
Statistics (ONS) and the National Health Service Breast
Screening Programme (NHSBSP) in the recording of incident
screen-detected breast cancer histology between 1996 and
2001.
Methods 1.3 million women aged 50 to 64 years were recruited
into the Million Women Study cohort via the NHSBSP. Incident
screen-detected breast cancer histologies were notified
separately by the ONS and NHSBSP. ICD-10 and ICD-02 ONS
codes and NHSBSP histology data were similarly coded to
allow for comparison in terms of cancer invasiveness and
morphology. The statistical outcome measures are percentage
agreement and the kappa statistic.
Results A total of 5,886 incident screen-detected breast
cancers were available for analysis. Of the 5,886 screen-
detected cancers reported by the ONS and NHSBSP, 5,684
(96.6%, κ = 0.9) agreed in terms of the degree of invasiveness.
Of the 5,458 cancers that had been assigned a specific
morphology code, there was exact agreement between the
ONS and the NHSBSP in 4,922 cases (90.2%, κ = 0.8).
Conclusion There is an excellent level of agreement between
the ONS and NHSBSP in the recording of the histology of
screen-detected breast cancer. From these results it is not
possible to comment on which source of data is the more or less
accurate, although the differences are very small.
Introduction
Many epidemiological studies use cancer registration data col-
lected by the Office for National Statistics (ONS) and it is
important that the data are reliable. The completeness and
accuracy of cancer registration at a national and regional level
have been evaluated [1] but no study has specifically exam-
ined the agreement in the reporting of breast cancer histology
between the ONS and another national database. In this
paper, we use data collected in the Million Women Study [2]
to compare the agreement in the recording of breast cancer
histology between the ONS and the National Health Service
Breast Screening Programme (NHSBSP) for incident screen-
detected breast cancers.
Materials and methods
The Million Women Study is a multicentre cohort study involv-
ing over one million women across the UK. The methods of the
study are described in detail elsewhere [2]. Briefly, women
aged between 50 and 64 years and registered within the
National Health Service were recruited into the study via the
NHSBSP between 1996 and 2001. All women recruited are
flagged on the National Health Service Central Register so
that incident cancers in the study cohort are notified to the
study coordinating centre. In addition, information on screen-
detected breast cancer is obtained directly from the NHSBSP.
Therefore, for each screen-detected breast cancer, informa-
tion about the cancer histology has been obtained from two
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sources, the ONS and NHSBSP. The ONS provides data as
ICD-10 site codes and ICD-02 (International Classification of
Diseases) histology codes covering both invasive (C50) and
non-invasive (D05) breast carcinomas [3]. These codes have
been assigned by cancer registry staff at a regional level [4].
The data from the NHSBSP is obtained directly from screen-
ing centres. The data are not coded at the centres, and in
order to be able to make comparisons between the cancer his-
tology data from each source, the NHSBSP data were classi-
fied by Million Women Study staff into one of the 15
categories shown in Table 1. Staff coding the NHSBSP data
were unaware of the codes provided by ONS.
This analysis is based on Million Women Study participants
who had been diagnosed with a screen detected breast can-
cer in England between March 1996 and March 2001. Data
from the NHSBSP and ONS were compared to see whether
they agreed in terms of the degree of cancer invasiveness and
with respect to histological classification. In both the ONS and
NHSBSP data, if there was notification of both non-invasive
and invasive disease in the same woman within a six month
time period, the more aggressive tumour recorded was used
for comparisons. It was assumed that these notifications
related to the same primary cancer. If the NHSBSP recorded
more than one invasive histological diagnosis (e.g. invasive
ductal cancer and invasive tubular cancer), we allowed any of
the diagnoses to agree with the corresponding ONS code for
invasive cancer. If the ONS reported more than one breast
cancer in the same woman within a six month time period, it
was assumed that this was the same primary cancer and only
the most aggressive tumour reported was used for coding.
When evaluating the level of agreement for histology coding,
the analysis was restricted to those neoplasms that had been
assigned a specific histology code (Table 1). Analyses were
also performed to see how well the data agreed across Eng-
lish regional cancer registries and over time in terms of degree
of cancer invasiveness.
Percentage agreement and the kappa statistic are the statisti-
cal outcome measures in the study. The kappa statistic is a
statistical measure that calculates the agreement between two
observations in excess of the amount of agreement that would
arise purely by chance. A kappa value (κ) can range from zero
to one. A kappa value of 0 indicates that the agreement is due
to chance and a value of 1 indicates perfect agreement. Gen-
erally a kappa value κ > 0.8 is considered to show very good
agreement [5].
All analyses were performed using the statistical package
Stata, version 8.0 (Stata Corporation, College Station, TX,
USA).
Results
In total, 5,941 incident screen-detected breast cancers diag-
nosed between 1996 and 2001 were notified to the Million
Women Study by the NHSBSP and ONS. More than one his-
Table 1
Coding categories for breast cancer histologies reported in Million Women Study participants
NHSBSP descriptive data ONS ICD-02 codes
Invasive ductal carcinoma 8022/3, 8141/3, 8201/3, 8500/3, 8501/3, 8521/3
Invasive lobular carcinoma 8520/3
Invasive tubular carcinoma 8211/3
Invasive mixed carcinoma 8522/3
Invasive mucinous carcinoma 8480/3
Other specified invasive histology 8041/3, 8050/1, 8200/3, 8246/3, 8401/3, 8810/3, 8502/3, 8503/3, 8504/3, 8550/3, 8560/3, 9020/3
Non-specified invasive histology 8530/3, 8140/3, 8000/3, 8001/3, 8003/3, 8010/3
Ductal carcinoma in situ 8230/2, 8500/2, 8500/5, 8501/2, 8501/5, 8521/2
Lobular carcinoma in situ 8520/2, 8520/5
Ductal + lobular carcinoma in situ 8522/2
Pagets 8540/3
Other specified non-invasive 
histology




Unable to code 8000/1, 8520, 8500/6
ICD, International Classification of Diseases; NHSBSP, National Health Service Breast Screening Programme; ONS, Office for National 
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tology code within a six month time period was reported by the
ONS in 33 out of 5,941 cases (<1%). In 52 (0.88%) of the
cases, histology data from the NHSBSP was incomplete and
in 3 (0.05%) of the cases, the ONS histology information was
incomplete. These 55 cancers were excluded from the analy-
sis, leaving 5,886 (99%) cases with complete information on
histology from both sources available for the comparisons.
Agreement of invasive versus non-invasive disease
Among the 5,886 screen-detected cancers included in the
analysis, the overall prevalence of invasive disease was very
similar according to information from both the ONS and NHS-
BSP, at 80% (4,715/5,886) and 79% (4,621/5,886), respec-
tively (Table 2). In 5,684 (96.6%) cases, there was agreement
as to whether the cancer was invasive or non-invasive (κ =
0.90; Table 2). Where there was disagreement, 148 (2.5%)
cases were recorded by the ONS as invasive and NHSBSP as
non-invasive, whereas only 54 (<1%) cases were recorded by
the NHSBSP as invasive and ONS as non-invasive. The disa-
greement in the recording of invasive and non-invasive disease
in these small number of cases was significant (X2
1 = 6.1, p =
0.01).
The level of agreement between invasive and non-invasive dis-
ease ranged between 92% and 100% in each calendar year
of registration (κ = 0.7 to 0.9: Table 3). There was a significant
improvement in the level of agreement over time (X2
1 = 5.2, p
= 0.02).
Across the cancer registry regions of England, the level of
agreement between invasive and non-invasive disease was
between 88% and 98% (κ = 0.9 to 1.0; Table 4).
Agreement of tumour histology
Of the 5,886 cases shown in Table 2, 377 cases (329 ONS,
66 NHSBSP with 18 cases recorded as 'non-specified inva-
sive histology' by the ONS and NHSBSP) were categorised
as 'non-specified invasive histology' and 51 cases (51 ONS, 0
NHSBSP) as 'non-specified non-invasive histology'. This left
5,458 (93%) cases with 1 of 12 specific histology codings
(Table 1). Of these 5,458 cases, the ONS and NHSBSP had
recorded the same specified histology in 4,922 cases (90.2%,
κ = 0.8; Table 5).
For the invasive carcinomas, both sources reported ductal car-
cinoma as the most common type. Both sources also reported
that ductal carcinoma in situ (DCIS) is by far the most common
type of non-invasive cancer. Tables 6 and 7 show the alterna-
tive histology coding assigned to a cancer when the ONS and
Table 2
Overall agreement of invasive and non-invasive histologies in 
participants of the Million Women Study
NHSBSP Total
ONS Invasive Non-invasive
Invasive 4,567 148 4,715
Non-invasive 54 1,117 1,171






p0 . 0 1
NHSBSP, National Health Service Breast Screening Programme; 
ONS, Office for National Statistics.
Table 3
Agreement of invasive and non-invasive cancer histologies 
over time in participants of the Million Women Study
Year Number of cases Percentage agreement κ value
1996 102a 0.92 0.73
1997 1,093 0.94 0.84
1998 2,018 0.96 0.89
1999 1,572 0.96 0.89
2000 773 0.97 0.91
2001 315b 0.95 0.86
aLower number of cases in 1996 as this is the first year of recruitment 
into the Million Women Study.
bLower number of cases in 2001 as only cases diagnosed up to the 
end of March 2001 were included in the analysis. Test for trend: X2
1 
= 5.2, p = 0.02.
Table 4
Agreement of invasive and non-invasive cancer histologies in 
the regional cancer registries of England in participants of the 
Million Women Study
Region Number of casesa Percentage agreement κ value
A 1,830 0.96 0.87
B 737 0.97 0.91
C 691 0.97 0.92
D 490 0.95 0.82
E 486 0.94 0.85
F 485 0.96 0.89
G 410 0.98 0.93
H 389 0.97 0.94
I 189 0.97 0.86
J 180 0.88 0.66
aVariation in the number of cases is a reflection of the variation in the 
number of participating breast cancer screening centres within each 
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NHSBSP disagreed over whether the case was invasive duc-
tal carcinoma or DCIS. Six coding categories are shown: inva-
sive ductal carcinoma, 'other specified invasive histology',
'other non-specified invasive histology', DCIS, 'other specified
non-invasive histology' and 'other non-specified non-invasive
histology'.
Table 6 shows the histology code the NHSBSP reported
when the ONS recorded a case as an invasive ductal carci-
noma or DCIS. When the ONS recorded invasive ductal car-
cinoma histology, the NHSBSP did so as well in 93% (3,017/
3,228) of cases. Of the remaining 7%, 3% (90/3,228) were
coded as 'other specified invasive histology', <1% as other
invasive carcinomas with non-specified histology (19/3,228)
and 3% (101/3,228) as DCIS. When the ONS recorded
histology as DCIS, the NHSBSP did so in 95% (976/1,032)
of cases. Of the remaining 6%, 3% (30/1,032) were coded as
invasive ductal carcinoma, 2% (20/1,032) as other invasive
carcinomas of either specified or non-specified histology and
<1% (6/1,032) as non-invasive carcinoma of no specified
histology.
Table 7 shows the histology code the ONS reported when the
NHSBSP recorded a case as invasive ductal carcinoma or
DCIS. When the NHSBSP recorded a case as invasive ductal
carcinoma, the ONS assigned the same code in 88% (3,017/
3,442) of cases. Of the remaining 12%, 5% (167/3,442) were
coded as specified invasive carcinomas with other histologies,
6% (224/3,442) as other invasive carcinomas with non-spec-
ified histologies and only 1% (35/3,442) as non-invasive car-
cinoma. When the NHSBSP recorded a case as DCIS, the
ONS did so in 82% (976/1,191) of cases. Of the remaining
18%, 8% (101/1,191) were coded as invasive ductal carci-
noma, <1% (8/1,191) as invasive histology of another
specified type, 3% (31/1,191) as other invasive histologies of
a non-specified type, 3% (30/1,191) as other specified non-
invasive histologies and 4% (45/1,191) as other non-invasive
histologies of a non-specified type.
Discussion
The method of cancer registration in England is well docu-
mented [4]. The coordinating centre for cancer registration in
England is the National Cancer Intelligence Centre, part of the
ONS. Until 1993, cancer registration was voluntary. Since Jan-
Table 5
































Invasive ductal 3,017 20 46 14 6 4 0 101 1 1 1 0 3,211
Invasive lobular 32 515 9 1 9 33014 0 0 0 5 8 6
Invasive tubular 39 1 280 2 00110 0 0 0 3 2 4
Invasive mixed 68 19 1 14 21010 0 0 0 1 0 6
Other specified 
invasive
2 1 44023 0050 0 0 0 5 7
Invasive mucinous 3 0 1 3 1 42 100 0 0 0 5 1
Invasive medullary 4 0 0 1 0 2 13 00 0 0 0 2 0
Ductal carcinoma 
in situ
3 0 100 0 0 1 976 3 3 8 0 1,022
Lobular carcinoma 
in situ
0000 0 0 0 5 32 05 0 4 2
Other specified 
non-invasive
1 0 0 0 0 0 01 80 0 01 2 0
Ducal + lobular 
carcinoma in situ
0 0 0 0 00071 0 10 01 8
P a g e t s 0 1 0 0 00000 0 0 0 1




Kappa statistic 13 0.8
NHSBSP, National Health Service Breast Screening Programme; ONS, Office for National Statistics.Available online http://breast-cancer-research.com/content/7/6/R1090
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uary 1993 it has become a mandatory requirement for National
Health Service trusts to provide the core items outlined in the
cancer registration minimum dataset to the National Cancer
Intelligence Centre. Cancer registries obtain free text
pathology reports from pathology laboratories and currently
data entry in most registries relies on the interpretation of the
free text in pathology reports by trained coders. However, the
free text in pathology reports is primarily used as a tool for
communication between clinicians to enable them to make
informed management choices about their patients, not as a
tool for cancer registration [6]. It has been shown that guide-
lines and computerised forms significantly improve the quality
of histopathology reporting by pathologists and simplify data
entry for coders at the registries [6].
The NHSBSP was set up in 1988 and by the mid 1990s had
achieved national coverage. National standards have been set
in reference to all aspects of breast screening and these are
monitored within a robust national quality assurance network.
In addition, the NHSBSP audits its own work through the Brit-
ish Association of Surgical Oncology and other quality assur-
ance groups and standardised pathology reporting is the norm
[7]. The guidelines for pathology reporting are detailed and
provide a standardised framework through which all patholo-
gists can work [8]. As with the ONS, the NHSBSP extracts
data from pathology reports.
The Million Women Study is collecting data on incident
screen-detected breast cancers from both the ONS and NHS-
BSP. Although The Million Women Study has participants in
England and Scotland, in this paper we only examine cancer
Table 6
Number of cases and percentage agreement between Office for National Statistics and National Health Service Breast Screening 
Programme in relation to invasive ductal carcinoma, ductal carcinoma in situ and other invasive and non-invasive histologies in 
participants of the Million Women Study
ONS assigned histology code
Invasive ductal carcinoma Ductal carcinoma in situ
NHSBSP histology
Invasive ductal carcinoma 3,017 93% 30 <1%
Other specified invasive histology 90 3% 4 <1%
Other non-specified invasive histology 19 <1% 16 2%
Ductal carcinoma in situ 101 3% 976 95%
Other specified non-invasive histology 1 <1% 6 <1%
Other non-specified non-invasive histology 0 0 0 0
Total 3,228 100% 1,032 100%
NHSBSP, National Health Service Breast Screening Programme; ONS, Office for National Statistics.
Table 7
Number of cases and percentage agreement between National Health Service Breast Screening Programme and Office for National 
Statistics in relation to invasive ductal carcinoma, ductal carcinoma in situ and other invasive and non-invasive histologies in 
participants of the Million Women Study
NHSBSP assigned histology code
Invasive ductal carcinoma Ductal carcinoma in situ
ONS histology
Invasive ductal carcinoma 3,017 88% 101 8%
Other specified invasive histology 167 5% 8 <1%
Other non-specified invasive histology 224 6% 31 3%
Ductal carcinoma in situ 30 <1% 976 82%
Other specified non-invasive histology 1 <1% 30 3%
Other non-specified non-invasive histology 3 <1% 45 4%
Total 3,442 100% 1,191 100%
NHSBSP, National Health Service Breast Screening Programme; ONS, Office for National Statistics.Breast Cancer Research    Vol 7 No 6    Gathani et al.
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registration in England as the ONS does not cover Scotland.
Of the 5,941 incident screen-detected breast cancers diag-
nosed in study participants between 1996 and 2001, only 55
(1%) cases were excluded from these analyses because of
missing data on histology. The histology information from the
ONS was extremely complete, with only 3/5,941 (0.05%)
cases without such information. The histology information from
the NHSBSP was also very complete, with only 52/5,941
(0.88%) cases without such data.
Among women with histology recorded by both the ONS and
NHSBSP, the overall level of agreement between the two
sources was excellent, with over 95% (κ = 0.9) agreement in
terms of degree of invasiveness. Where there was disagree-
ment in regard to the degree of invasiveness, there was a
greater tendency for the ONS to report a histology as invasive
when the NHSBSP had recorded it as non-invasive, than for
the NHSBSP to report a histology as invasive when the ONS
recorded a non-invasive histology (2.5% versus <1%).
Although the difference in the reporting of invasive and non-
invasive histologies was statistically significant, it should be
noted that the disagreements are restricted to a very small pro-
portion of the total number of cases (3.5%) and that overall the
level of agreement for invasive and non-invasive histologies is
excellent.
With regard to the agreement for 12 specified histological
types, the level of agreement was still excellent, at around 90%
(κ = 0.8), with invasive ductal carcinoma contributing the
greatest numbers to the invasive histologies and DCIS con-
tributing the greatest numbers to the non-invasive histologies.
When the ONS records an invasive ductal carcinoma, the
N H S B S P  d o e s  s o  i n  9 3 %  o f  c a s e s ,  a n d  w h e n  t h e  O N S
records a DCIS, the NHSBSP does so in 94% of cases. How-
ever, when the NHSBSP records a diagnosis of invasive duc-
tal carcinoma, the ONS does so in 88% of cases, and when
the NHSBSP records a DCIS, the ONS does so in 82% of
cases.
In the future, with the planned implementation of the National
Health Service National Information Technology (IT)
Programme within the next 10 years, cancer registration will
be facilitated as information technology practices are stand-
ardised across England [9]. The apparent improvement of the
levels of agreement over time between the ONS and NHSBSP
within the short time period studied was statistically signifi-
cant; however, it should be noted that the level of agreement
was very good in all the years studied. Again, with increasing
use of information technology one might expect to see further
improvements over time in the future. The minor variation seen
between different registries is not unexpected and only one
registry had a kappa value of less than 0.8 for agreement
between invasive and non-invasive histologies. The local can-
cer registries are independent and currently differ considera-
bly in their method of data collection, with some being fully
automated with all information flowing electronically and oth-
ers relying on hospital staff to extract data for the registries [4].
The agreement in the recording of breast cancer incidence by
the ONS and general practitioner reports has been examined
using the General Practice Research Database; the level of
agreement between the two sources was found to be high
[10]. The Merseyside and Cheshire regional cancer registry
has examined all the cancers registered by them in one year
and found that the quality of data varied by age of patient, can-
cer site and area of residence, with breast cancer being no
exception [1]. To our knowledge, no existing UK based study
has specifically evaluated the agreement of breast cancer his-
tology by the ONS with another national programme.
It is not within the scope of this study to comment on whether
the histology data from the ONS are more or less accurate
than the histology data from the NHSBSP. We can only com-
ment on what the level of agreement is between them and
highlight where disagreements occur. Nevertheless, the
results of this study show that the information on breast cancer
histology from the ONS is very complete and that there is
good agreement with the NHSBSP histology data.
Conclusion
Information on breast cancer histology from either the ONS or
NHSBSP is sufficiently reliable to be used for epidemiological
studies, and in particular for long-term prospective studies.
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